Greetings, and welcome to the Synergy Pharmaceuticals' Business Update Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation ...

Synergy CHC Corp. beats earnings expectations. Reported EPS is $0.01239, expectations were $0.01. Operator: Good morning, everyone, and thank you for participating in today’s conference call to ...

Synergy CHC Corp reported a notable decline in its Q4 2025 financial performance, with net revenue falling by 41% year-over-year to $6.07 million. The company’s gross margin and operating income were ...

Operator: Good morning, everyone, and thank you for participating in today’s conference call to discuss Synergy CHC Corporation’s financial results for the fourth quarter and full year ended December ...

Earnings call Q4 revenue fell 41% year-over-year due to the reversal of a $2.5M international license and inventory write-offs, but normalized margins and core supplement sales remain stable.

Good morning, everyone, and thank you for participating in today's conference call to discuss Synergy CHC Corporation's Financial Results for the Third Quarter ended September 30, 2025. Joining us ...

Synergy CHC Corp. (NASDAQ:SNYR) Q3 2025 Earnings Call Transcript November 13, 2025 Synergy CHC Corp. beats earnings expectations. Reported EPS is $0.01239, expectations were $0.01. Operator: Good ...